Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyObservational Study Published on 2023-02-012023-07-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), [키워드] booster COVID-19 multiple sclerosis SARS-CoV-2 vaccine. [DOI] 10.1016/j.msard.2022.104486 PMC 바로가기 [Article Type] Observational Study
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individualsArticle Published on 2023-01-232023-07-11 Journal: Vaccine [Category] COVID19(2023년), [키워드] antibodies booster Hybrid immunity omicron SARS-CoV-2 vaccine. [DOI] 10.1016/j.vaccine.2022.12.049 PMC 바로가기
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trialClinical Trial Published on 2023-01-012023-07-11 Journal: EBioMedicine [Category] COVID19(2023년), [키워드] Bivalent protein vaccine booster immunogenicity Safety. SARS-CoV-2 SCTV01C [DOI] 10.1016/j.ebiom.2022.104386 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant womenArticle Published on 2023-01-012023-07-10 Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), [키워드] antibodies booster COVID-19 humoral immune response immune response Immunity Messenger RNA vaccine SARS-CoV-2 Transplacental antibody transfer vaccination. [DOI] 10.1016/j.ajog.2022.07.014 PMC 바로가기
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLLArticle Published on 2023-01-012023-07-10 Journal: European journal of haematology [Category] COVID19(2023년), [키워드] BNT162b2 mRNA booster chronic lymphocytic leukemia CLL COVID-19 COVID-19 vaccine immune response. [DOI] 10.1111/ejh.13878 PMC 바로가기
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective글로벌 관점에서 COVID-19 백신 부스터의 물류 판단Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] booster booster vaccination booster vaccinations COVID-19 COVID-19 vaccination COVID-19 vaccine Effectiveness equity Immune escape Immune-mediated immunocompromised individuals implementation indicate Perspective Premature protective immunity protocol response SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Side effects vaccination Vaccine Vaccine hesitancy vaccine. variant viral evolution waning immunity weighed [DOI] 10.1080/21645515.2021.2020572 PMC 바로가기 [Article Type] Article
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron VariantArticle Published on 2022-12-192023-07-09 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), [키워드] booster delta variant Omicron variant SARS-CoV-2 vaccine effectiveness. [DOI] 10.1093/cid/ciac328 PMC 바로가기
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infectionDelta 및 Omicron SARS-CoV-2 감염에 대한 동종 및 이종 BNT162b2, CoronaVac 및 AZD1222 추가 백신 접종의 실제 효과Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] AZD1222 BNT162b2 booster booster vaccination conducted CoronaVac country COVID-19 COVID-19 vaccines Delta demonstrated effective Effectiveness Evidence evidence of Heterologous heterologous booster homologous homologous booster Immune escape inactivated Malaysia National omicron percentage points recipient SARS-CoV-2 SARS-COV-2 infection the SARS-CoV-2 vaccination Vaccine vaccine effectiveness. Vaccines Viral viral variant [DOI] 10.1080/22221751.2022.2072773 PMC 바로가기 [Article Type] Article
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variantsArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition adenoviral vector Adenovirus adenovirus type 5 vector vaccine Anti-RBD IgG booster COVID-19 COVID-19 vaccine D614G demonstrated dose effective Efficacy IgA immunization Inactivated vaccine Inactivated Vaccines Inhaled lack mucosal Neutralization assay Neutralizing neutralizing antibody omicron Omicron variant BA.5 pandemic plasma Protective RBD SARS-CoV-2 SARS-CoV-2 pseudovirus SARS-CoV-2 vaccines SARS-CoV-2 variant subunit titre Vaccination strategies vaccination strategies. Vaccination strategy Vaccine variant virus widespread [DOI] 10.1080/22221751.2022.2132881 PMC 바로가기
Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccinationArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] Anti-spike Antibody Response B cell B cell responses BBIBP-CorV booster booster vaccination CD4 CD8 comparable COVID-19 COVID-19 vaccines de novo demonstrated detectable dramatic increase Epidemic exhibited Features humoral immune response Humoral immunity humoral responses interferon-γ Neutralizing antibodies omicron remained S protein SARS-CoV-2 SARS-COV-2 infection serotype Severe case Shanghai significantly T cell T cell response T cell responses T cell responses. Th1 cytokine vaccination vaccinee vaccinees wild type [DOI] 10.1080/22221751.2022.2130101 PMC 바로가기